Washington Trust’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-6
Closed -$7K 1008
2020
Q2
$7K Buy
+6
New +$5.2K ﹤0.01% 682

Other funds holding LABU

Washington Trust's LABU Position: Q3 2020 in Review

Washington Trust sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2020, closing a stake of 6 shares — an estimated $7K sold.

Washington Trust first reported a position in LABU in Q2 2020 and held it in 1 quarter. The position peaked at $7K in Q2 2020. 20 funds tracked by Wall St. Rank hold LABU as of Q3 2020.

  • Washington Trust reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2020 after selling out during the quarter.
  • Washington Trust sold 6 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2020, an estimated $7K.
  • Washington Trust first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2020 and held it in 1 quarter.
  • Washington Trust's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $7K in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2020.

Based on Washington Trust's 13F filing for Q3 2020, filed 5 Nov 2020.